Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rapoport

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
Journal of Hematopathology|March 27, 2025
Lifileucel (AMTAGVI) tumor-infiltrating lymphocyte morphology in CellaVision peripheral smear reviewsLaura M Wake, Rima Koka, Ariel A Fromowitz, et al.
Leukemia Research|March 22, 2003
Flavonoid effects on normal and leukemic cellsJane L Liesveld, Camille N Abboud, Chaohui Lu, et al.
Blood Cells, Molecules & Diseases|January 11, 2002
PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cellsM Simons-Evelyn, K Bailey-Dell, J A Toretsky, et al.
Leukemia Research|December 15, 2012
c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomasFang Hu, Ronald B Gartenhaus, Xianfeng F Zhao, et al.
Oncogene|May 30, 2012
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemiasL A Tobin, C Robert, A P Rapoport, et al.
Cancers|June 19, 2024
A Clinical Perspective on Plasma Cell Leukemia: A Single-Center ExperienceAndrew Y Li, Farin Kamangar, Noa G Holtzman, et al.
Transfusion|January 10, 2003
Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine AClarence Sarkodee-Adoo, Dan Sotirescu, Lyle Sensenbrenner, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myelomaAshraf Badros, Olga Goloubeva, Robert Fenton, et al.
American Journal of Hematology|October 6, 2006
Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution studyFrancis K Buadi, Meyer R Heyman, Christopher D Gocke, et al.
JCO Oncology Practice|August 1, 2020
Length of Stay and Hospital Costs for Patients Undergoing Allogeneic Stem-Cell TransplantationAmandeep Godara, Nauman S Siddiqui, Satish Munigala, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
Journal of Hematopathology|March 27, 2025
Lifileucel (AMTAGVI) tumor-infiltrating lymphocyte morphology in CellaVision peripheral smear reviewsLaura M Wake, Rima Koka, Ariel A Fromowitz, et al.
Leukemia Research|March 22, 2003
Flavonoid effects on normal and leukemic cellsJane L Liesveld, Camille N Abboud, Chaohui Lu, et al.
Blood Cells, Molecules & Diseases|January 11, 2002
PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cellsM Simons-Evelyn, K Bailey-Dell, J A Toretsky, et al.
Leukemia Research|December 15, 2012
c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomasFang Hu, Ronald B Gartenhaus, Xianfeng F Zhao, et al.
Oncogene|May 30, 2012
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemiasL A Tobin, C Robert, A P Rapoport, et al.
Cancers|June 19, 2024
A Clinical Perspective on Plasma Cell Leukemia: A Single-Center ExperienceAndrew Y Li, Farin Kamangar, Noa G Holtzman, et al.
Transfusion|January 10, 2003
Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine AClarence Sarkodee-Adoo, Dan Sotirescu, Lyle Sensenbrenner, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myelomaAshraf Badros, Olga Goloubeva, Robert Fenton, et al.
American Journal of Hematology|October 6, 2006
Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution studyFrancis K Buadi, Meyer R Heyman, Christopher D Gocke, et al.
JCO Oncology Practice|August 1, 2020
Length of Stay and Hospital Costs for Patients Undergoing Allogeneic Stem-Cell TransplantationAmandeep Godara, Nauman S Siddiqui, Satish Munigala, et al.
Pageof 18